Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up von Peters, S, Adjei, A A, Gridelli, C, Reck, M, Kerr, K, Felip, E

Volltext

The association of financial difficulties with clinical outcomes in cancer patients: secondary analysis of 16 academic prospective clinical trials conducted in Italy von Perrone, F., Jommi, C., Di Maio, M., Gimigliano, A., Gridelli, C., Pignata, S., Ciardiello, F., Nuzzo, F., de Matteis, A., Del Mastro, L., Bryce, J., Daniele, G., Morabito, A., Piccirillo, M.C., Rocco, G., Guizzaro, L., Gallo, C.

Volltext

Metastatic non-small-cell lung cancer: consensus on pathology and molecular tests, first-line, second-line, and third-line therapy 1st ESMO Consensus Conference in Lung Cancer; Lug... von FELIP, E, GRIDELLI, C, BAAS, P, ROSELL, R, STAHEL, R

Volltext

Management of elderly patients with NSCLC; updated expert's opinion paper: EORTC Elderly Task Force, Lung Cancer Group and International Society for Geriatric Oncology von Pallis, A.G., Gridelli, C., Wedding, U., Faivre-Finn, C., Veronesi, G., Jaklitsch, M., Luciani, A., O'Brien, M.

Volltext

EORTC Elderly Task Force and Lung Cancer Group and International Society for Geriatric Oncology (SIOG) experts’ opinion for the treatment of non-small-cell lung cancer in an elderl... von Pallis, A.G., Gridelli, C., van Meerbeeck, J.P., Greillier, L., Wedding, U., Lacombe, D., Welch, J., Belani, C.P., Aapro, M.

Volltext

Phase III Randomized Trial Comparing Three Platinum-Based Doublets in Advanced Non–Small-Cell Lung Cancer von Scagliotti, G V, De Marinis, F, Rinaldi, M, Crinò, L, Gridelli, C, Ricci, S, Matano, E, Boni, C, Marangolo, M, Failla, G, Altavilla, G, Adamo, V, Ceribelli, A, Clerici, M, Di Costanzo, F, Frontini, L, Tonato, M

Volltext

42IN ADVANCED NSCLC: MAINTENANCE WITH TARGETED THERAPIES von Gridelli, C

Volltext

Immunotherapy in the first-line treatment of elderly patients with advanced non-small-cell lung cancer: results of an International Experts Panel Meeting by the Italian Association... von Gridelli, C., Peters, S., Velcheti, V., Attili, I., de Marinis, F.

Volltext

Cilengitide combined with cetuximab and platinum-based chemotherapy as first-line treatment in advanced non-small-cell lung cancer (NSCLC) patients: results of an open-label, rando... von Vansteenkiste, J., Barlesi, F., Waller, C.F., Bennouna, J., Gridelli, C., Goekkurt, E., Verhoeven, D., Szczesna, A., Feurer, M., Milanowski, J., Germonpre, P., Lena, H., Atanackovic, D., Krzakowski, M., Hicking, C., Straub, J., Picard, M., Schuette, W., O'Byrne, K.

Volltext

First-line immunotherapy in advanced non-small-cell lung cancer patients with ECOG performance status 2: results of an International Expert Panel Meeting by the Italian Association... von Gridelli, C., Peters, S., Mok, T., Forde, P.M., Reck, M., Attili, I., de Marinis, F.

Volltext

Gefitinib as first-line treatment for patients with advanced non-small-cell lung cancer with activating epidermal growth factor receptor mutation: Review of the evidence von Gridelli, C, De Marinis, F, Di Maio, M, Cortinovis, D, Cappuzzo, F, Mok, T

Volltext

Chemotherapy for Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Multicenter Italian Lung Cancer in the Elderly Study (MILES) Phase III Randomized Trial von Gridelli, Cesare, Perrone, Francesco, Gallo, Ciro, Cigolari, Silvio, Rossi, Antonio, Piantedosi, Francovito, Barbera, Santi, Ferraù, Francesco, Piazza, Elena, Rosetti, Francesco, Clerici, Maurizia, Bertetto, Oscar, Robbiati, Sergio Federico, Frontini, Luciano, Sacco, Cosimo, Castiglione, Federico, Favaretto, Adolfo, Novello, Silvia, Migliorino, Maria Rita, Gasparini, Giampietro, Galetta, Domenico, Iaffaioli, Rosario Vincenzo, Gebbia, Vittorio

Volltext

Role of Theatre as Psychological Support in Cancer Patient von Barzelloni, M.L., Serrao, S., Stanco, A., Mazza, S., Gridelli, C.

Volltext

nab-paclitaxel + carboplatin induction followed by nab-paclitaxel maintenance in squamous non-small cell lung cancer (NSCLC): Results from the ABOUND.sqm study von Spigel, D.R., Jotte, R.M., Ponce Aix, S., Gressot, L., Morgensztern, D., McCleod, M., Socinski, M.A., Daniel, D., Juan-Vidal, O., Kim, E.S., West, H.J., Chen, T., Bhore, R., Ong, T.J., Gridelli, C., Thomas, M.

Volltext

34IN SYSTEMIC TREATMENT von Gridelli, C

Volltext

A randomized, double-blind, phase II study of erlotinib with or without sunitinib for the second-line treatment of metastatic non-small-cell lung cancer (NSCLC) von Groen, H.J.M., Socinski, M.A., Grossi, F., Juhasz, E., Gridelli, C., Baas, P., Butts, C.A., Chmielowska, E., Usari, T., Selaru, P., Harmon, C., Williams, J.A., Gao, F., Tye, L., Chao, R.C., Blumenschein, G.R.

Volltext

Genetic counseling for BRCA1/BRCA2 testing von Rossi, E., Rosania, C., Ventruto, M.L., Serrao, S., Colantuoni, G., Iannace, C., Russo, G., Buono, M., Gridelli, C.

Volltext

Secondary ROS1 mutations and lorlatinib sensitivity in crizotinib-refractory ROS1 positive NSCLC: Results of the prospective PFROST trial von Landi, L., Tiseo, M., Heukamp, L.C., Menon, R., Spitaleri, G., Cortinovis, D.L., Delmonte, A., Galetta, D., D’Arcangelo, M., D’Incà, F., Bertrand, M., Jóri, B., Zacher, A., Gridelli, C., Novello, S., Chiari, R., Verusio, C., Crinò, L., Cappuzzo, F.

Volltext

First line chemotherapy in advanced or metastatic NSCLC von Rinaldi, M., Cauchi, C., Gridelli, C.

Volltext

Brigatinib (BRG) vs crizotinib (CRZ) in the phase III ALTA-1L trial von Califano, R., Hochmair, M.J., Gridelli, C., Delmonte, A., Garcia Campelo, M.R., Bearz, A., Griesinger, F., Morabito, A., Felip, E., Ghosh, S., Tiseo, M., Haney, J., Kerstein, D., Popat, S., Camidge, D.R.

Volltext